The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 460-466

  Yamada, Kiyofumi ^b   Noda, Yukihiro ^a   Hasegawa, Takaaki ^a   Komori, Yumiko ^a   Nikai, Toshiaki ^b   Sugihara, Hisayoshi ^b   Nabeshima, Toshitaka ^a,b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; ARGININE; DIBUTYRYL CYCLIC GMP; DIZOCILPINE MALEATE; DRUG DERIVATIVE; HEMOGLOBIN; N ACETYL S NITROSOPENICILLAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENICILLAMINE;

ANIMAL; ARTICLE; AVOIDANCE BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; MALE; MAZE TEST; MEMORY; MOUSE; PHYSIOLOGY; STEREOISOMERISM;

ANIMALS; ARGININE; AVOIDANCE LEARNING; DIBUTYRYL CYCLIC GMP; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; HEMOGLOBINS; MALE; MAZE LEARNING; MEMORY; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PENICILLAMINE; RECEPTORS, N-METHYL-D-ASPARTATE; S-NITROSO-N-ACETYLPENICILLAMINE; STEREOISOMERISM;

EID: 0030088028     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. ANISMAN, H.: Dissociation of disinhibitory effects of scopolamine: Strain and task factors. Pharmacol. Biochem. Behav. 3: 613-618, 1975.
2. AOKI, E., SEMBA, R., MIKOSHIBA, K. AND KASHIWAMATA S.: Predominant localization in glial cells of free L-arginine Immunocytochemical evidence. Brain Res. 547: 190-192, 1991.
3. BANNERMAN, D. M , CHAPMAN, P. F., KELLY, A. T., BUTCHER, S. P. AND MORRIS, R. G. M.: Inhibition of nitric oxide synthase does not impair spatial learning. J. Neurosci. 14: 7404-7414, 1994a.
4. BANNERMAN, D M., CHAPMAN, P. F., KELLY, A. T., BUTCHER, S. P. AND MORRIS, R. G. M.: Inhibition of nitric oxide synthase does not prevent the induction of long-term potentiation in vivo. J. Neurosci. 14: 7415-7425, 1994b.
5. BENINGER, R J., JHAMANDAS, K., BOEGMAN, R. J. AND EL-DEFRAWY, S. R.: Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats. Pharmacol. Biochem. Behav. 24: 1353-1360, 1986.
6. BOHME, G. A., BON, C , LEMAIRE, M., REIBAUD, M., PIOT, O., STUTZMANN, J. M., DOBLE, A. AND BLANCHARD, J. C.: Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc. Natl. Acad. Sci. U.S.A. 90: 9191-9194, 1993.
7. BREDT, D. S. AND SNYDER, S. H.: Nitric oxide mediates glutamate-linked enhancement of cGmp levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A. 86: 9030-9033, 1989
8. G-Nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil. Eur. J. Pharmacol. 260:191-200, 1994.
9. CHAPMAN, P. F., ATKINS, C. M., ALLEN, M. T., HALEY, J. E. AND STEINMETZ, J. E.: Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport 3: 567-570, 1992.
10. COLLINGRIDGE, G. L., KEHL, S. J. AND MCLENNAN, H.: Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. 334: 33-46, 1983.
11. DAWSON, T. M. AND SNYDER, S H.: Gases as biological messengers: Nitric oxide and carbon monoxide in the brain. J. Neurosci. 14: 5147-5159, 1994.
12. DAWSON, V. L., DAWSON, T. M., BARTLEY, D A., UHL, G. R. AND SNYDER, S. H.: Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci 13: 2651-2661, 1993.
13. DAWSON, V. L., DAWSON, T. M., LONDON, E. D., BREDT, D. S. AND SNYDER, S. H.: Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc. Natl. Acad. Sci. U.S.A. 88: 6368-6371, 1991.
14. DECKER, M. W., TRAN, T. AND MCGAUGH, J. L.: A comparison of the effects of scolopamine and diazepam on acquisition and retention of inhibitory avoidance in mice. Psychopharmacology 100: 515-521, 1990.
15. G-nitroarginine in brain in vitro and in vivo. Biochem. Biophys. Res. Commun. 176: 1136-1141, 1991.
16. EAST, S. J. AND GARTHWAITE, J.: NMDA receptor activation in rat hippocampus induces cyclic Gmp formation through the L-arginine-nitric oxide pathway. Neurosci. Lett. 123: 17-19, 1991.
17. FLEXNER, L. B. AND FLEXNER, J. B.: Effect of acetoxycycloheximide and of an acetocycloheximide-puromycin mixture on cerebral protein synthesis and memory. Proc. Natl. Acad. Sci. U.S.A. 55: 369-374, 1966.
18. GARTHWAITE, J., CHARLES, S. L. AND CHESS-WILLIAMS, R.: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385-388, 1988.
19. GARTHWAITE, J., GARTHWAITE, G., PALMER, R. M. J AND MONCADA, S.: NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 172: 413-416, 1989.
20. HABERNY, K. A., POU, S. AND ECOLES, C.: Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci. Lett. 146: 187-190, 1992.
21. HALEY, T. J. AND MCCORMICK, W. G.: Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12: 12-15, 1957.
22. HALEY, J. E., WILCOX, G. L. AND CHAPMAN, P. F.: The role of nitric oxide in hippocampal long-term potentiation. Neuron 8: 211-216, 1992.
23. HANSEL, C., BATCHELOR, A., CUÉNOD, M., GARTHWAITE, J., KNOPFEL, T. AND DO, K. Q.: Delayed increase of extracellular arginine, the nitric oxide precursor, following electrical white matter stimulation in rat cerebellar slices. Neurosci. Lett. 142: 211-214, 1992.
24. HIRAMATSU, M., CHO, A. K. AND NABESHIMA, T.: Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and pheneyclidine. Eur. J. Pharmacol. 166: 359-366, 1989.
25. HÖLSCHER, C. AND ROSE, S. P. R.: Inhibiting synthesis of the putative retrograde messenger nitric oxide results in amnesia in a passive avoidance task in the chick. Brain Res. 619:189-194, 1993.
26. ICHIHARA, K., NABESHIMA, T. AND KAMEYAMA, T.: Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice. Pharmacol. Biochem. Behav. 30: 107-113, 1988a.
27. ICHIHARA, K, NABESHIMA, T. AND KAMEYAMA, T.: Effects of haloperidol, sulpiride and Sch 23390 on passive avoidance learning in mice. Eur. J. Pharmacol. 151: 435-442, 1988b.
28. ICHIHARA, K., NABESHIMA, T. AND KAMEYAMA, T.: Differential effects of pimozide and Sch 23390 on acquisition of learning in mice. Eur J. Pharmaeol. 164: 189-195, 1989.
29. 2 receptors. Eur. J. Pharmacol. 213: 243-249, 1992.
30. KNOWLES, R. G., PALACIOS, M., PALMER, R. M. J. AND MONCADA, S.: Formation of nitric oxide from L-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad Sci. U.S.A. 86: 5169-5162, 1989.
31. LALONDE, R. AND VIKIS-FREIBERGS, V.: Manipulations of 5-HT activity and memory in the rat. Pharmacol. Biochem. Behav. 22: 377-382, 1985.
32. LÖSCHER, W., ANNIES, R. AND HONACK, D.: The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128: 191-194, 1991.
33. LOWRY O. H., ROSEBROUGH N. J., FARR A. L. AND RANDALL R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
34. MARTIN, W., VILLANI, G. M , JOTHIANANDAN, D. AND FURCHGOTT, R. F.: Selective blockade of endothelium-dependent and glyceryl trimtrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232: 708-716, 1985.
35. 2 antagonists on druginduced imapirment of passive avoidance response in mice: Comparison with acetylcholinesterase inhibitors. Psychopharmacology 112:134-141, 1993.
36. MAURICE, T., HIRAMATSU, M., ITOH, J., KAMEYAMA, T., HASEGAWA, T. AND NABESHIMA, T.: Behavioral evidence for a modulating role of σ ligands in momory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res. 647: 44-56, 1994.
37. MCCASLIN, P. P. AND MORGAN, W. W.: Continuously infused 2-amino-7- phosphonoheptanoic acid antagonizes N-methyl-D-aspartate-induced elevations of cyclic GMP in vivo in multiple brain areas and chemically-induced seizure activity. Neuropharmacology 25: 905-909, 1986.
38. MONDADORI, C., WEISKRANTZ, L., BUERKI, H., PETSCHKE, F. AND FAGG, G. E.: NMDA receptor antagonists can enhance or impair learning performance in animals. Exp. Brain Res. 75: 449-456, 1989.
39. MORRIS, R. G. M., AMDERSON, E., LYNCH, G. S. AND BAUDRY, M.: Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP-5. Nature 319: 774-776, 1986.
40. MÜLSHE, A., LÜCKHOFF, A., POHL, U., BUSSE, R. AND BASSENGE, E.: LY83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation. Naunyn-Schmideberg's Arch Pharmacol. 1989: 113-125, 1989.
41. NABESHIMA, T., NODA, Y. AND KAMEYAMA, T.: Role of cholinergic and GABAergic neuronal systems in cycloheximide-induced amnesia in mice. Pharmacol. Biochem. Behav. 31: 405-409, 1988.
42. NABESHIMA, T., ICHIHARA, K., TOHYAMA, K., MURASE, K., SUZUKI, T. AND KAMEYAMA, T.: Involvement of serotonergic neuronal systems in the anti-amnesic action of naftidrofuryl oxalate. Eur. J. Pharmacol. 205: 55-61, 1991a.
43. 2 receptor antagonist on cycloheximide-induced amnesia in mice. Pharmacol. Biochem. Behav. 32: 787-790, 1989.
44. 1A receptor agonists on the passive avoidance task in mice. Res Commun. Psychol. Psychiatry Behav. 17: 87-108, 1992.
45. A and mucsarinic receptors induced by cycloheximide. J. Pharmacol. Exp. Ther. 257: 271-275, 1991b.
46. NAKAMURA, T., YAMADA, K., HASEGAWA, T. AND NABESHIMA, T.: Possible involvement of nitric oxide in quinolinic acid-induced convulsion in mice. Pharmacol. Biochem. Behav. 51: 309-312, 1995.
47. NOWICKI, J. P., DUVAL, D., POIGNET, H. AND SCATTON, B.: Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204: 339-340, 1991.
48. O'DELL, T. J., HAWKINS, R. D., KANDEL, E. R. AND ARANCIO, O.: Tests of the roles of two diffusible substances in long-term potentiation: Evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. U.S.A. 88: 11285-11289, 1991.
49. PARADA, J., CZUCZWAR, S. J. AND TURSKI, W. A.: NBQX does not affect learning and memory tasks in mice: A comparison with D-CPPene and ifenprodil. Cognit. Brain Res. 1: 67-71, 1992.
50. PARADA-TURSKA, J. AND TURSKI, W. A.: Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmaeology 29:1111-1116, 1990.
51. PRZEGALINSKI E., BARAN, L. AND SIWANOWICZ, J.: The role of nitric oxide in the kainate-induced seizures in mice Neurosci. Lett. 170: 74-76, 1994.
52. 3H]dopamine uptake. Brain Res. 641: 83-91, 1994.
53. REES, D. D., PALMER, R. M. J., SCHULZ, R., HODSON, H. F. AND MONCADA, S.: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101: 746-752, 1990.
54. ROBERTS, P. J., FOSTER G. A., SHARIF N. A. AND COLLINS, J. F.: Phosphonate analogues of acidic amino acids: inhibition of excitatory amino acid transmitter binding to cerebellar membranes and of stimulation of cerebellai cyclic GMP levels. Brain Res. 238: 475-479, 1982.
55. SARTER, M., BODEWITZ, G. AND STEPHENS, D. N.: Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but no inverse agonist and agonist β-carbolins. Psychopharmacology 94: 491-495, 1988.
56. SCHUMAN, E. M. AND MADISON D. V.: A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254:1503-1506, 1991
57. SNYDER, S. H.: Nitric oxide: First in a new class of neurotransmitters. Science 257: 494-496, 1992.
58. WALDMAN, S. A. AND MURAD, F.: Cyclic GMP synthesis and function. Pharmacol Rev. 39: 163-196, 1987.
59. WARD, L., MASON S. E. AND ABRAHAM, W. C.: Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats. Pharmacol Biochem. Behav. 35: 785-790, 1990.
60. WHITTON, P. S., BIGGS, C. S., PEARCE, B. R. AND FOWLER, L. J.: MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo J. Neurochem. 58: 1573-1575, 1992.
61. WOOD, P. L., EMMETT, M. R., RAO, T. S., CLER, J., MICK, S. AND IYENGAR, S: Inhibition of nitric oxide synthase blocks N-methyl-D-aspartate-, quisqual ate-, kainate-, harmaline-, and pentylenetetrazole-dependent increases in cerebellar cyclic GMP in vivo. J. Neurochem. 55: 346-348, 1990.
62. YAMADA, K., NAKAYAMA, S., SHIOTANI, T., HASEGAWA, T. AND NABESHIMA, T: Possible involvement of the activation of voltage-sensitive calcium channels in the ameliorating effects of nefiraeetam on scopolamine-induced impairment of performance in a passive avoidance task. J. Pharmacol. Exp. Ther. 270 881-892, 1994.
63. YAMADA, K., NODA, Y., NAKAYAMA S., KOMORI, Y., SUGIHARA, H., HASEGAWA, T. AND NABESHIMA, T.: Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br. J. Pharmacol. 115: 852-858, 1995.
64. ZHUO, M., HU, Y., SCHULTZ, C., KANDEL, E. R. AND HAWKINS, R. D.: Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 368: 635-639, 1994.